Lannett Company Inc
NYSE:LCI
Intrinsic Value
Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of LCI.
Lannett Company Inc's market capitalization is 290k USD.
LCI stock price is 0.0269 USD.
LCI.
LCI. Open DCF Valuation
LCI. Open Relative Valuation
LCI.
LCI has positive Gross Profit for the last twelve months.
LCI has negative Free Cash Flow for the last twelve months.
LCI's Revenue has dropped by 29% over the past 12 months.
LCI has negative Operating Income for the last twelve months.
LCI has negative Net Income for the last twelve months.
LCI's long-term liabilties (747m USD) exceed its long-term assets (335m USD).
LCI's short-term liabilties (733m USD) exceed its short-term assets (262m USD).
LCI has positive Net Debt. This means that the company has more debt (628m USD) than cash and short-term investments (47m USD).
LCI doesn't generate enough operating income (-70m USD) to safely cover interest payments on its debt (31m USD).
Fundamental Analysis
Lannett Company Inc
Balance Sheet Decomposition
Lannett Company Inc
Lannett Company Inc
Earnings Waterfall
Lannett Company Inc
|
Revenue
|
340.6m
USD
|
|
Cost of Revenue
|
-307.4m
USD
|
|
Gross Profit
|
33.2m
USD
|
|
Operating Expenses
|
-103.4m
USD
|
|
Operating Income
|
-70.2m
USD
|
|
Other Expenses
|
-161.4m
USD
|
|
Net Income
|
-231.6m
USD
|
Free Cash Flow Analysis
Lannett Company Inc
What is Free Cash Flow?
LCI Profitability Score
Profitability Due Diligence
Lannett Company Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Score
Lannett Company Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
LCI Solvency Score
Solvency Due Diligence
Lannett Company Inc's solvency score is 23/100. The higher the solvency score, the more solvent the company is.
Score
Lannett Company Inc's solvency score is 23/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LCI Price Targets Summary
Lannett Company Inc
Ownership
LCI Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
LCI Price
Lannett Company Inc
| Average Annual Return | -25.7% |
| Standard Deviation of Annual Returns | 47.85% |
| Max Drawdown | -100% |
| Market Capitalization | 290k USD |
| Shares Outstanding | 10 766 600 |
| Percentage of Shares Shorted | 13.28% |
Company Profile
Lannett Company Inc
Country
Industry
Market Cap
Dividend Yield
Description
Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. The company is headquartered in Trevose, Pennsylvania and currently employs 812 full-time employees. The company went IPO on 2002-04-15. The firm's products include Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; Posaconazole DR Tablets, which are used to prevent fungal infections in people; Verapamil SR tablets are a calcium channel blocker used in the treatment of high blood pressure, arrhythmia and angina; Methylphenidate CD Capsules used for the treatment of Attention Deficit Hyperactivity Disorder; Omeprazole Capsules, which is indicated for the treatment of certain diseases of the esophagus and stomach ulcers; Pantoprazole Sodium DR Tablets, which is a proton pump inhibitor, indicated for the treatment of certain diseases of the esophagus and pathological hypersecretory conditions; and Sumatriptan Nasal Spray, which is indicated for the acute treatment of migraine attacks.
You don't have any saved screeners yet
